Tibet Cheezheng Tibetan Medicine Co., Ltd. (SHE: 002287)
China
· Delayed Price · Currency is CNY 23.09
-1.03 (-4.27%)
Oct 11, 2024, 3:04 PM CST
Tibet Cheezheng Tibetan Medicine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | 594.62 | 581.2 | 472.54 | 715.88 | 403.96 | 364.25 | Upgrade
|
| Depreciation & Amortization | 116.6 | 90.37 | 83.19 | 65.83 | 43.79 | 36.03 | Upgrade
|
| Other Amortization | 5.14 | 5.4 | 2.72 | 2.08 | 0.05 | 0.05 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.17 | -0.32 | -0 | 0.07 | 0.35 | -1.81 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.24 | 0.3 | 1.22 | 16.13 | 0.04 | 0.01 | Upgrade
|
| Loss (Gain) From Sale of Investments | -30.29 | -69.31 | 32.86 | -328.81 | -12.66 | -17.19 | Upgrade
|
| Provision & Write-off of Bad Debts | -0.21 | 1.27 | 0.74 | -1.36 | 0.82 | -0.18 | Upgrade
|
| Other Operating Activities | 58.94 | 60.95 | 54.9 | 48.66 | 20 | 21.35 | Upgrade
|
| Change in Accounts Receivable | 1,149 | 41.95 | -209.3 | 369.7 | -349.1 | -101.96 | Upgrade
|
| Change in Inventory | -10.8 | -28.46 | -10.65 | -24.04 | -32.47 | -1.9 | Upgrade
|
| Change in Accounts Payable | -1,375 | 9.79 | -146.43 | 136.6 | 94.45 | 110.34 | Upgrade
|
| Change in Other Net Operating Assets | 24.51 | 24.51 | 12.38 | -4.61 | 84.63 | - | Upgrade
|
| Operating Cash Flow | 512.17 | 693.41 | 285.69 | 1,035 | 237.67 | 405.95 | Upgrade
|
| Operating Cash Flow Growth | 87.90% | 142.72% | -72.40% | 335.44% | -41.45% | -18.71% | Upgrade
|
| Capital Expenditures | -363.56 | -234.81 | -272.4 | -125.57 | -339.37 | -52.27 | Upgrade
|
| Sale of Property, Plant & Equipment | 0 | 0.04 | - | 0 | 0.31 | 1.91 | Upgrade
|
| Cash Acquisitions | - | - | - | -61.11 | - | - | Upgrade
|
| Investment in Securities | 346.1 | -354.28 | -92.56 | -1,984 | -269.25 | 410 | Upgrade
|
| Other Investing Activities | 274.02 | 278.47 | 30.46 | 14.98 | 16.41 | 18.22 | Upgrade
|
| Investing Cash Flow | 256.57 | -310.59 | -334.5 | -2,155 | -591.91 | 377.85 | Upgrade
|
| Long-Term Debt Issued | - | 750 | 806.39 | 500 | 690 | 300 | Upgrade
|
| Total Debt Issued | 903.5 | 750 | 806.39 | 500 | 690 | 300 | Upgrade
|
| Long-Term Debt Repaid | - | -961.85 | -645.26 | -347.38 | -450 | - | Upgrade
|
| Total Debt Repaid | -1,168 | -961.85 | -645.26 | -347.38 | -450 | - | Upgrade
|
| Net Debt Issued (Repaid) | -264.08 | -211.85 | 161.13 | 152.62 | 240 | 300 | Upgrade
|
| Issuance of Common Stock | 0.5 | - | - | 0.16 | 794.35 | 33.04 | Upgrade
|
| Common Dividends Paid | -219.48 | -220.05 | -340.51 | -195.54 | -193.19 | -167.13 | Upgrade
|
| Other Financing Activities | -0.6 | -0.6 | -3.84 | - | -2.16 | 0.3 | Upgrade
|
| Financing Cash Flow | -483.66 | -432.5 | -183.22 | -42.76 | 839.01 | 166.2 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.51 | 0.61 | 2.97 | -0.75 | -2.26 | 1.23 | Upgrade
|
| Net Cash Flow | 284.56 | -49.07 | -229.06 | -1,164 | 482.51 | 951.24 | Upgrade
|
| Free Cash Flow | 148.6 | 458.59 | 13.29 | 909.35 | -101.7 | 353.68 | Upgrade
|
| Free Cash Flow Growth | 68.37% | 3350.89% | -98.54% | - | - | -4.53% | Upgrade
|
| Free Cash Flow Margin | 6.68% | 22.42% | 0.65% | 51.36% | -6.85% | 25.21% | Upgrade
|
| Free Cash Flow Per Share | 0.28 | 0.87 | 0.03 | 1.72 | -0.19 | 0.67 | Upgrade
|
| Cash Income Tax Paid | 271.61 | 284.33 | 243.7 | 270.37 | 255.79 | 212.15 | Upgrade
|
| Levered Free Cash Flow | 76.44 | 457.62 | -2.83 | 576.99 | -360.91 | 236.52 | Upgrade
|
| Unlevered Free Cash Flow | 128.39 | 497.04 | 32.43 | 610.38 | -346.97 | 239.43 | Upgrade
|
| Change in Net Working Capital | -71.97 | -343.48 | 112.2 | -402.87 | 281.36 | -42.46 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.